Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma

References

• BouffetETaboriUHuangABartelsUPossibilities of new therapeutic strategies in brain tumorsCancer Treat Rev201036433534120188479
   PubMed Web of Science ®Google Scholar
• OmuroADeAngelisLMGlioblastoma and other malignant gliomas: a clinical reviewJAMA2013310171842185024193082
   PubMed Web of Science ®Google Scholar
• PawICarpenterRCWatabeKDebinskiWLoHWMechanisms regulating glioma invasionCancer Lett201528362(1)1725796440
   PubMedGoogle Scholar
• BickerJAlvesGFortunaAFalcãoABlood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a reviewEur J Pharm Biopharm201487340943224686194
   PubMed Web of Science ®Google Scholar
• PardridgeWMBlood-brain barrier deliveryDrug Discov Today2007121–2546117198973
   PubMed Web of Science ®Google Scholar
• HuangMKeYSunXMammalian target of rapamycin signaling is involved in the vasculogenic mimicry of glioma via hypoxia-inducible factor-1αOncol Rep20143251973198025175735
   PubMedGoogle Scholar
• LiuXMZhangQPMuYGClinical significance of vasculogenic mimicry in human gliomasJ Neurooncol2011105217317921533525
   PubMed Web of Science ®Google Scholar
• ChenYSChenZPVasculogenic mimicry: a novel target for glioma therapyChin J Cancer2014332747923816560
   PubMedGoogle Scholar
• JuRJLiXTShiJFLiposomes, modified with PTD(HIV-1) peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancerBiomaterials201435267610762124912818
   PubMed Web of Science ®Google Scholar
• CooperISassonKTeichbergVISchnaider-BeeriMFridkinMShechterYPeptide derived from HIV-1 TAT protein destabilizes a monolayer of endothelial cells in an in vitro model of the blood-brain barrier and allows permeation of high molecular weight proteinsJ Biol Chem201228753446764468323150670
   PubMedGoogle Scholar
• RaoKSReddyMKHorningJLLabhasetwarVTAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugsBiomaterials200829334429443818760470
   PubMed Web of Science ®Google Scholar
• QinYChenHYuanWLiposome formulated with TAT-modified cholesterol for enhancing the brain deliveryInt J Pharm20114191–2859521807083
   PubMedGoogle Scholar
• LiuYLuWRecent advances in brain tumor-targeted nano-drug delivery systemsExpert Opin Drug Deliv20129667168622607535
   PubMed Web of Science ®Google Scholar
• de la FuenteJMBerryCCTat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleusBioconjug Chem20051651176118016173795
   PubMed Web of Science ®Google Scholar
• ZhangPCheethamAGLinYACuiHSelf-assembled Tat nanofibers as effective drug carrier and transporterACS Nano2013775965597723758167
   PubMed Web of Science ®Google Scholar
• TakiHKanazawaTAkiyamaFTakashimaYOkadaHIntranasal delivery of camptothecin-loaded Tat-modified nanomicells for treatment of intracranial brain tumorsPharmaceuticals (Basel)20125101092110224281259
   PubMedGoogle Scholar
• SimonMJKangWHGaoSBantaSMorrisonB3rdIncreased delivery of TAT across an endothelial monolayer following ischemic injuryNeurosci Lett201048611420851169
   PubMed Web of Science ®Google Scholar
• PloskerGLFauldsDEpirubicin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapyDrugs19934557888567686469
   PubMed Web of Science ®Google Scholar
• CowellIGAustinCAMechanism of generation of therapy related leukemia in response to anti-topoisomerase II agentsInt J Environ Res Public Health2012962075209122829791
   PubMed Web of Science ®Google Scholar
• CrivellariDPaganiOVeronesiAHigh incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxelAnn Oncol200112335335611332148
   PubMedGoogle Scholar
• TuriniMEDuBoisRNCyclooxygenase-2: a therapeutic targetAnnu Rev Med200253355711818462
   PubMed Web of Science ®Google Scholar
• LiuXYuePZhouZKhuriFRSunSYDeath receptor regulation and celecoxib-induced apoptosis in human lung cancer cellsJ Natl Cancer Inst200496231769178015572759
   PubMed Web of Science ®Google Scholar
• VichaiVKirtikaraKSulforhodamine B colorimetric assay for cytotoxicity screeningNat Protoc2006131112111617406391
   PubMed Web of Science ®Google Scholar
• LiXYZhaoYSunMGMultifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain gliomaBiomaterials201435215591560424726749
   PubMed Web of Science ®Google Scholar
• KostarelosKEmfietzoglouDPapakostasAYangWHBallangrudASgourosGBinding and interstitial penetration of liposomes within avascular tumor spheroidsInt J Cancer2004112471372115382056
   PubMed Web of Science ®Google Scholar
• LiuTSunBZhaoXHER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinomaJ Cell Mol Med201317111612223279650
   PubMed Web of Science ®Google Scholar
• ChenYJingZLuoCVasculogenic mimicry-potential target for glioblastoma therapy: an in vitro and in vivo studyMed Oncol201229132433121161444
   PubMedGoogle Scholar
• FuJWangDMeiDMacrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancerJ Control Release2015204111925646783
   PubMed Web of Science ®Google Scholar
• FriedrichKWiederTVon HaefenCOverexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistanceOncogene2001202224492460
   Google Scholar
• MerinoDLokSWVisvaderJELindemanGJTargeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancerOncogene Epub2015810
   Google Scholar
• SciumèGSheltonSGrayWA multiphase model for three-dimensional tumor growthNew J Phys201315015005
   PubMedGoogle Scholar
• HendrixMJSeftorEAHessARSeftorREVasculogenic mimicry and tumour-cell plasticity: lessons from melanomaNat Rev Cancer20033641142112778131
   PubMed Web of Science ®Google Scholar
• TangNNZhuHZhangHJHIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cellsWorld J Gastroenterol20142047178941790425548487
   PubMed Web of Science ®Google Scholar
• ZhangSZhangDSunBVasculogenic mimicry: current status and future prospectsCancer Lett2007254215716417306454
   PubMed Web of Science ®Google Scholar
• BazileDPrud’hommeCBassoulletMTMarlardMSpenlehauerGVeillardMStealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes systemJ Pharm Sci19958444934987629743
   PubMed Web of Science ®Google Scholar